134 related articles for article (PubMed ID: 6461438)
21. Development of a new laboratory test to evaluate antithrombin resistance in plasma.
Murata M; Takagi A; Suzuki A; Okuyama E; Takagi Y; Ando Y; Kato I; Nakamura Y; Murate T; Matsushita T; Saito H; Kojima T
Thromb Res; 2014 Feb; 133(2):293-8. PubMed ID: 24325876
[TBL] [Abstract][Full Text] [Related]
22. On the quantification of prothrombin from different species using Echis carinatus as activator.
Tollersrud OK; Helgeland L
Thromb Res; 1986 Jun; 42(6):737-47. PubMed ID: 3523815
[TBL] [Abstract][Full Text] [Related]
23. Prothrombin fragment 1 + 2 and thrombin-antithrombin complex measurements indicate continuous and progressive intraoperative thrombin generation in liver transplantation.
Monteagudo J; Reverter JC; Pereira A; Pijoan J; Balust J; Escolar G; Mazzara R; Taurá P; Visa J; Ordinas A
Haemostasis; 1993; 23(1):51-7. PubMed ID: 8477908
[TBL] [Abstract][Full Text] [Related]
24. Disseminated intravascular coagulation following Echis carinatus venom in dogs: effects of a synthetic thrombin inhibitor.
Schaeffer RC; Briston C; Chilton SM; Carlson RW
J Lab Clin Med; 1986 Jun; 107(6):488-97. PubMed ID: 3086470
[TBL] [Abstract][Full Text] [Related]
25. An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition.
Demers C; Henderson P; Blajchman MA; Wells MJ; Mitchell L; Johnston M; Ofosu FA; Fernandez-Rachubinski F; Andrew M; Hirsh J
Thromb Haemost; 1993 Mar; 69(3):231-5. PubMed ID: 8470046
[TBL] [Abstract][Full Text] [Related]
26. Determination of human thrombin-antithrombin III complex by enzyme immunoassay.
Heimburger N; Pelzer H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):269-73. PubMed ID: 2465214
[TBL] [Abstract][Full Text] [Related]
27. Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa.
Ofosu FA; Hirsh J; Esmon CT; Modi GJ; Smith LM; Anvari N; Buchanan MR; Fenton JW; Blajchman MA
Biochem J; 1989 Jan; 257(1):143-50. PubMed ID: 2920007
[TBL] [Abstract][Full Text] [Related]
28. Prothrombin Clamart: prothrombin variant with defective Arg 320-IIe cleavage by factor Xa.
Huisse MG; Dreyfus M; Guillin MC
Thromb Res; 1986 Oct; 44(1):11-21. PubMed ID: 3787558
[TBL] [Abstract][Full Text] [Related]
29. Substitution of Gly-548 to Ala in the substrate binding pocket of prothrombin Perijá leads to the loss of thrombin proteolytic activity.
Sekine O; Sugo T; Ebisawa K; Umeyama H; Iwahana H; Ruiz-Sáez A; de Bosch N; Matsudai M
Thromb Haemost; 2002 Feb; 87(2):282-7. PubMed ID: 11858488
[TBL] [Abstract][Full Text] [Related]
30. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
[TBL] [Abstract][Full Text] [Related]
31. Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin III.
MacGregor IR; Lane DA; Kakkar VV
Biochim Biophys Acta; 1979 Sep; 586(3):584-93. PubMed ID: 476156
[TBL] [Abstract][Full Text] [Related]
32. Thrombin-antithrombin III and prothrombin fragment 1.2 levels in early respiratory distress syndrome.
Yurdakök M; Yigit S; Gürakan B; Dündar S; Kirazli S
Am J Hematol; 1996 Mar; 51(3):247-8. PubMed ID: 8619412
[No Abstract] [Full Text] [Related]
33. The use of a commercial ELISA for assay of thrombin-antithrombin complexes in purified systems.
Elgue G; Pasche B; Blombäck M; Olsson P
Thromb Haemost; 1990 Jun; 63(3):435-8. PubMed ID: 2205949
[TBL] [Abstract][Full Text] [Related]
34. Molar antithrombin concentration in normal human plasma.
Conard J; Brosstad F; Lie Larsen M; Samama M; Abildgaard U
Haemostasis; 1983; 13(6):363-8. PubMed ID: 6667903
[TBL] [Abstract][Full Text] [Related]
35. Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers.
Slaughter TF; LeBleu TH; Douglas JM; Leslie JB; Parker JK; Greenberg CS
Anesthesiology; 1994 Mar; 80(3):520-6. PubMed ID: 8141448
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
[TBL] [Abstract][Full Text] [Related]
37. Action of crotalase, an enzyme with thrombin-like and kallikrein-like specificities, on tripeptide nitroanilide derivatives.
Simmons G; Bundalian M; Theodor I; Martinoli J; Pirkle H
Thromb Res; 1985 Nov; 40(4):555-61. PubMed ID: 2934864
[TBL] [Abstract][Full Text] [Related]
38. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
[TBL] [Abstract][Full Text] [Related]
39. L-asparaginase induced antithrombin III deficiency: evidence against the production of a hypercoagulable state.
Bauer KA; Teitel JM; Rosenberg RD
Thromb Res; 1983 Feb; 29(4):437-42. PubMed ID: 6857592
[TBL] [Abstract][Full Text] [Related]
40. Influence of hormone replacement therapy (17 beta-OH estradiol and medroxyprogesterone acetate) on plasma concentration of prothrombin fragment F1+2 and thrombin-antithrombin III complex in postmenopausal woman.
Ciepłluch R; Czestochowska E
Acta Haematol Pol; 1996; 27(1):21-5. PubMed ID: 8629439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
